Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution

Neuraminidase inhibitors (NAIs) are the only available licensed therapeutics against human H7N9 influenza virus infections. The emergence of NAI-resistant variants of H7N9viruses with an NA R292K mutation poses a therapeutic challenge. A comprehensive understanding of the susceptibility of these vir...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Emerg Microbes Infect
Auteurs principaux: Zhang, Xiaonan, Song, Zhigang, He, Jing, Yen, Hui-Ling, Li, Jianhua, Zhu, Zhaoqin, Tian, Di, Wang, Wei, Xu, Lei, Guan, Wencai, Liu, Yi, Wang, Sen, Shi, Bisheng, Zhang, Wanju, Qin, Boyin, Cai, Jialin, Wan, Yanmin, Xu, Chunhua, Ren, Xiaonan, Chen, Haili, Liu, Lu, Yang, Yuqin, Zhou, Xiaohui, Zhou, Wenjiang, Xu, Jianqing, Zhang, Xiaoyan, Peiris, Malik, Hu, Yunwen, Yuan, Zhenghong
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274890/
https://ncbi.nlm.nih.gov/pubmed/26038501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2014.80
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires